Finance

Lists
Why is GYRE down 9.03%?
Dive Deeper
GYRE:NASDAQ
Gyre Therapeutics Inc
US$4.23
-9.03%
(-0.42) 1D
US$4.29
+1.42% (+0.060)
After hours
Closed: ኖቬም 10, 4:00:00 ከሰዓት ጂ ኤም ቲ-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for GYRE...
Open
US$4.63
High
US$4.63
Low
US$4.22
Mkt. cap
462.98 ሚ
Avg. vol.
170.22 ሺ
Volume
141.06 ሺ
52-wk high
US$9.14
52-wk low
US$4.00
EPS
-US$0.20
Beta
2.43
Shares outstanding
106.03 ሚ
No. of employees
625
Open
US$4.63
High
US$4.63
Low
US$4.22
Mkt. cap
462.98 ሚ
Avg. vol.
170.22 ሺ
Volume
141.06 ሺ
52-wk high
US$9.14
52-wk low
US$4.00
EPS
-US$0.20
Beta
2.43
Shares outstanding
106.03 ሚ
No. of employees
625
News stories
From web sources and news partners
TradingView
TradingView
·
ከ34 ደቂቃዎች በፊት
Can The S&P 500 Keep Rising In 2027? UBS Bets On 8,900, But BofA Warns Of Crowded Trades
Yahoo Finance
Yahoo Finance
·
ከ20 ደቂቃዎች በፊት
S&P 500 Sell-Off: 1 Investing Step to Take Right Now, and 1 Risky Move to Avoid
조선일보
조선일보
·
ከ1 ሰዓት በፊት
Anthropic Targets $1.4 Trillion Valuation in Nasdaq Listing
Bloomberg.com
Bloomberg.com
·
ከ4 ሰዓቶች በፊት
What to Know About the Anthropic IPO
About Gyre Therapeutics Inc
CEO-
Employees625
Founded1997
Headquartersዊንስተን-ሳሌም, ኖርዝ ካሮላይና, ዩናይትድ ስቴትስ
SectorHealth Care
IndustryBiotechnology
Websitegyretx.com
Analyst ratings
Based on 1 analyst giving stock ratings to GYRE in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for GYRE in the last 3 months
Highest
Current US$4.23
US$18.00 (+325.53%)
Average
US$18.00 (+325.53%)
Lowest
US$18.00 (+325.53%)
Analyst
Recommendation
Action
Price target
Projected
Date
Matthew Keller
H.C. Wainwright
Buy
Reiterated
US$18.00
+325.5%
11/06/2026
Robert LeBoyer
Noble Financial
Buy
Reiterated
US$20.00
+372.8%
08/10/2026
Roger Song
Jefferies
Buy
Initiated
US$16.00
+278.3%
10/10/2025
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
ዲሴም 2025
ማርች 2026
ጁን 2026
ሴፕቴ 2026
Revenue
37.20 ሚ
24.43 ሚ
29.10 ሚ
32.93 ሚ
Cost of goods sold
1.74 ሚ
1.23 ሚ
2.21 ሚ
1.95 ሚ
Cost of revenue
1.74 ሚ
1.23 ሚ
2.21 ሚ
1.95 ሚ
Research and development expenses
4.82 ሚ
11.48 ሚ
19.14 ሚ
8.51 ሚ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
30.52 ሚ
24.31 ሚ
21.62 ሚ
23.95 ሚ
Operating expense
35.33 ሚ
35.79 ሚ
40.76 ሚ
32.46 ሚ
Total operating expenses
37.08 ሚ
37.02 ሚ
42.97 ሚ
34.40 ሚ
Operating income
120.00 ሺ
-12.59 ሚ
-13.86 ሚ
-1.47 ሚ
Other non operating income
-2.31 ሚ
244.00 ሺ
-1.19 ሚ
-913.00 ሺ
EBT including unusual items
-66.00 ሺ
-18.03 ሚ
-18.34 ሚ
-1.74 ሚ
EBT excluding unusual items
-864.00 ሺ
-11.65 ሚ
-13.93 ሚ
-1.70 ሚ
Income tax expense
1.30 ሚ
549.00 ሺ
-164.00 ሺ
733.00 ሺ
Effective tax rate
-1,969.70%
-3.04%
0.89%
-42.01%
Other operating expenses
-
-
-
-
Net income
-1.72 ሚ
-10.30 ሚ
-14.51 ሚ
-4.05 ሚ
Net profit margin
-4.63%
-42.16%
-49.85%
-12.31%
Earnings per share
0.05
-
-
-
Interest and investment income
1.35 ሚ
743.00 ሺ
1.14 ሚ
688.00 ሺ
Interest expense
-
-
-
-
Net interest expenses
1.35 ሚ
743.00 ሺ
1.14 ሚ
688.00 ሺ
Depreciation and amortization charges
-
-
-
-
EBITDA
815.00 ሺ
-11.92 ሚ
-12.38 ሚ
-1.00 ሚ
Gain or loss from assets sale
2.00 ሺ
16.00 ሺ
2.00 ሺ
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google መተግበሪያዎች